Lite Strategy, Inc. (NASDAQ: LITS) reported successful first-quarter results, highlighting their digital asset treasury strategy and pharmaceutical operations. They acquired 929,548 Litecoin tokens, becoming the first U.S.-listed company to adopt Litecoin as a primary reserve asset. Lite Strategy raised $100 million and entered a partnership with GSR for their digital asset strategy.

Lite Strategy rebranded from MEI Pharma to focus on LTC as its primary asset, launched a $25 million share repurchase program, and brought on key board members. They plan to evaluate clinical assets and consider opportunities for licensing or sale. As of September 30, 2025, the company had $12.21 million in working capital with no debt.

Lite Strategy, Inc. (NASDAQ: LITS) is the first U.S. publicly traded company to adopt Litecoin as its primary reserve asset. They aim to maximize the value of their assets for stockholders. Lite Strategy has a comprehensive corporate strategy around LTC and is committed to long-term success. For more information, visit their website.

Read more at GlobeNewswire: Lite Strategy Reports First Quarter Fiscal Year 2026